177 related articles for article (PubMed ID: 36726926)
21. Bacillus Calmette-Guérin (BCG) prostato-epididymitis in a patient treated for a non-invasive urothelial cancer: A case report.
Salif A; Bigirimana F; Willems S; Reichman G; Noels J; Wijngaert SVD; Lecomte S; Maillart E; Clevenbergh P
IDCases; 2024; 36():e01967. PubMed ID: 38699528
[TBL] [Abstract][Full Text] [Related]
22.
Meyer RK; Williams SJ; Lee TY
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100152. PubMed ID: 32140570
[TBL] [Abstract][Full Text] [Related]
23. Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer - A rare complication.
Ong K; Dyer J; Wilson M; Hayne D
Urol Case Rep; 2022 May; 42():102003. PubMed ID: 35116226
[TBL] [Abstract][Full Text] [Related]
24. Septic Shock After Intravesical Therapy With Bacillus Calmette-Guerin: A Case Report of a Rare Life-Threatening Complication.
Fernandes PF; Nunes P; Figueiredo A
Cureus; 2023 Oct; 15(10):e46563. PubMed ID: 37933342
[TBL] [Abstract][Full Text] [Related]
25. Mycobacterium bovis Cerebellar Abscess Following Treatment With Bacillus Calmette-Guérin.
Sheron MW; Holt SL; Ingram CW
J Pharm Pract; 2017 Jun; 30(3):378-380. PubMed ID: 26966140
[TBL] [Abstract][Full Text] [Related]
26. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
[TBL] [Abstract][Full Text] [Related]
27. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
[TBL] [Abstract][Full Text] [Related]
28. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
[TBL] [Abstract][Full Text] [Related]
29. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
30. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
Parent ME; Richer M; Liang P
Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
[TBL] [Abstract][Full Text] [Related]
31. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
Rentsch CA; Thalmann GN; Lucca I; Kwiatkowski M; Wirth GJ; Strebel RT; Engeler D; Pedrazzini A; Hüttenbrink C; Schultze-Seemann W; Torpai R; Bubendorf L; Wicki A; Roth B; Bosshard P; Püschel H; Boll DT; Hefermehl L; Roghmann F; Gierth M; Ribi K; Schäfer S; Hayoz S
Eur Urol Oncol; 2022 Apr; 5(2):195-202. PubMed ID: 35012889
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy.
Nemeth J; Stoiser B; Winkler HM; Müllauer L; Graninger W; Winkler S
Wien Klin Wochenschr; 2008; 120(3-4):121-3. PubMed ID: 18322775
[TBL] [Abstract][Full Text] [Related]
33. Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.
Marquez-Batalla S; Fraile-Villarejo E; Belhassen-García M; Gutierrez-Zubiaurre N; Cordero-Sánchez M
World J Clin Cases; 2014 Jul; 2(7):301-3. PubMed ID: 25032208
[TBL] [Abstract][Full Text] [Related]
34. [A case of sepsis caused by BCG (Bacillus Calmette Guerin) after its bladder instillation in a 71-year-old patient affected by bladder carcinoma].
Sica S; Vargas N; Glielmi G; Avino S; Ciarallo M
Infez Med; 1999; 7(4):257-259. PubMed ID: 12748448
[TBL] [Abstract][Full Text] [Related]
35. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
Gontero P; Oderda M; Mehnert A; Gurioli A; Marson F; Lucca I; Rink M; Schmid M; Kluth LA; Pappagallo G; Sogni F; Sanguedolce F; Schiavina R; Martorana G; Shariat SF; Chun F
J Urol; 2013 Sep; 190(3):857-62. PubMed ID: 23545101
[TBL] [Abstract][Full Text] [Related]
36. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
[TBL] [Abstract][Full Text] [Related]
37. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
[TBL] [Abstract][Full Text] [Related]
38. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
Ng KL; Chua CB
Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
[TBL] [Abstract][Full Text] [Related]
39. A mycotic aneurysm of the abdominal aorta caused by
Roeke T; Hovsibian S; Schlejen PM; Dinant S; Koster T; Waasdorp EJ
J Vasc Surg Cases Innov Tech; 2018 Jun; 4(2):122-125. PubMed ID: 29942898
[TBL] [Abstract][Full Text] [Related]
40. Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy.
Nielens N; Marot L; Baeck M
Int J Infect Dis; 2022 Apr; 117():247-250. PubMed ID: 33984512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
